Carolina Reduzzi, Assistant Professor of Cancer Biology Research in Medicine and Director of Cristofanilli CTC laboratory at Weill Cornell Medicine, shared a post on LinkedIn:
“ctDNA landscape analysis post CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer — Our new paper is out in Nature Portfolio Springer Nature
Thank you to all who contributed to this multi-institutional consortium analysis!”
More posts featuring Carolina Reduzzi.